A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Clinical trial NCT00516841 · TERMINATED

Trial details

NCT number: NCT00516841
Sponsor: Facet Biotech
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Neoplasms

Start date: 2007-08-01
Primary completion: 2008-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.